Henry Schein, Inc. (NASDAQ:HSIC) EVP Mark E. Mlotek sold 5,559 shares of the company’s stock in a transaction on Friday, March 17th. The stock was sold at an average price of $170.98, for a total transaction of $950,477.82. Following the transaction, the executive vice president now owns 40,426 shares of the company’s stock, valued at $6,912,037.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Henry Schein, Inc. (NASDAQ:HSIC) traded up 0.09% during midday trading on Monday, reaching $171.41. 366,792 shares of the company’s stock traded hands. The firm has a market cap of $13.57 billion, a PE ratio of 27.69 and a beta of 1.02. Henry Schein, Inc. has a 52-week low of $146.23 and a 52-week high of $183.00. The firm’s 50-day moving average is $168.06 and its 200 day moving average is $159.48.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, February 21st. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.03. The firm had revenue of $3.12 billion for the quarter, compared to analyst estimates of $3.08 billion. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.67 EPS. Equities research analysts expect that Henry Schein, Inc. will post $7.25 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Henry Schein (NASDAQ:HSIC)

Your IP Address:

Several large investors have recently made changes to their positions in HSIC. Coconut Grove Bank raised its stake in shares of Henry Schein by 1.2% in the third quarter. Coconut Grove Bank now owns 1,255 shares of the company’s stock worth $204,000 after buying an additional 15 shares during the last quarter. FineMark National Bank & Trust raised its stake in Henry Schein by 3.3% in the third quarter. FineMark National Bank & Trust now owns 651 shares of the company’s stock valued at $106,000 after buying an additional 21 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its stake in Henry Schein by 0.8% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 2,576 shares of the company’s stock valued at $391,000 after buying an additional 21 shares during the last quarter. Mn Services Vermogensbeheer B.V. raised its stake in Henry Schein by 1.8% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 2,104 shares of the company’s stock valued at $343,000 after buying an additional 37 shares during the last quarter. Finally, Pitcairn Co. raised its stake in Henry Schein by 1.9% in the fourth quarter. Pitcairn Co. now owns 1,997 shares of the company’s stock valued at $303,000 after buying an additional 37 shares during the last quarter. 90.91% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts recently weighed in on the stock. Robert W. Baird raised shares of Henry Schein from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $164.00 to $170.00 in a research note on Tuesday, January 3rd. Zacks Investment Research cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, January 9th. Leerink Swann set a $183.00 price objective on shares of Henry Schein and gave the stock a “hold” rating in a research note on Wednesday, February 22nd. Northcoast Research cut shares of Henry Schein from a “buy” rating to a “neutral” rating in a research note on Tuesday, December 6th. Finally, Deutsche Bank AG assumed coverage on shares of Henry Schein in a research note on Wednesday, March 15th. They issued a “hold” rating and a $174.00 price objective on the stock. Nine analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $180.84.

About Henry Schein

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.